Cholera

Cholera
CDC · Public domain · source
Name	Cholera
Field	Infectious disease

Cholera Cholera is an acute diarrheal illness caused by toxigenic strains of Vibrio cholerae that can lead to rapid dehydration and death if untreated. Historically associated with major 19th‑ and 20th‑century pandemics, the disease remains an ongoing public health concern in parts of Africa, South Asia, and humanitarian emergencies. Control relies on prompt rehydration, antimicrobial therapy for severe cases, improved water and sanitation, and oral cholera vaccines deployed in outbreak and endemic settings.

Overview

Cholera is caused by specific serogroups of Vibrio, principally strains of Vibrio cholerae O1 and Vibrio cholerae O139, which produce cholera toxin, an AB5 enterotoxin that dysregulates ion transport in enterocytes. The clinical syndrome ranges from asymptomatic carriage to profuse watery diarrhea termed "rice‑water stools," leading to hypovolemic shock and electrolyte derangements. The disease has shaped global public health institutions such as the World Health Organization, spurred epidemiologic studies by figures like John Snow, and influenced infrastructure projects including the development of modern sewer systems in cities like London and Paris. Contemporary responses involve coordination among agencies such as Médecins Sans Frontières, the United Nations Children's Fund, and national ministries of health during outbreaks.

Epidemiology

Cholera has caused multiple recorded pandemics beginning in the 19th century, affecting regions from India to Europe and the Americas. Endemic transmission persists in parts of Bangladesh, Haiti, Democratic Republic of the Congo, and Yemen, with seasonal peaks linked to climatic and environmental drivers studied by institutions like the Centers for Disease Control and Prevention and research groups at Johns Hopkins University and the London School of Hygiene & Tropical Medicine. Outbreak dynamics are influenced by population displacement during conflicts such as the Syrian civil war and natural disasters including the 2010 Haiti earthquake, which overwhelmed water and sanitation systems. Surveillance uses case definitions endorsed by WHO and data are reported through systems coordinated with organizations like the Global Task Force on Cholera Control.

Pathophysiology and Microbiology

The pathogenic mechanism centers on colonization of the small intestine by toxigenic Vibrio cholerae O1 or O139, facilitated by motility via polar flagella and regulated by quorum sensing systems studied in microbiology labs at institutions like the Pasteur Institute and National Institutes of Health. The bacterium harbors the CTXϕ bacteriophage that encodes cholera toxin (CT), which ADP‑ribosylates the Gsα subunit of adenylate cyclase regulators, increasing intracellular cyclic AMP and causing chloride and water secretion. Host factors including stomach acidity, blood type (notably ABO blood group associations), and intestinal microbiota influence susceptibility; classic epidemiologic work was performed by investigators such as Robert Koch and later molecular characterization by researchers at Harvard Medical School and University of Oxford. Environmental reservoirs include coastal brackish waters and plankton, with Vibrio ecology intersecting with studies by the Scripps Institution of Oceanography and marine biology programs at Woods Hole Oceanographic Institution.

Clinical Presentation and Diagnosis

Presentation ranges from mild diarrhea to fulminant dehydration with tachycardia, hypotension, sunken eyes, and oliguria. Laboratory diagnosis is typically by stool culture on selective media in clinical microbiology laboratories associated with hospitals like Mayo Clinic and reference centers such as the National Institute for Communicable Diseases; rapid diagnostic tests and PCR assays are used by field teams from organizations like Centers for Disease Control and Prevention during outbreaks. Differential diagnosis includes enteric infections from Salmonella, Shigella, Escherichia coli, and protozoa investigated by centers including the London School of Hygiene & Tropical Medicine and the Wellcome Trust. Point‑of‑care assessment of electrolyte abnormalities uses biochemical analyzers developed and deployed by companies and laboratories collaborating with institutions such as Imperial College London.

Treatment and Management

Immediate treatment prioritizes oral rehydration solution (ORS) recommended in WHO guidelines and intravenous fluid resuscitation for severe dehydration using crystalloids in settings supported by clinical teams from Médecins Sans Frontières and national emergency medical services. Adjunctive antimicrobial therapy—agents such as azithromycin, doxycycline, or ciprofloxacin—reduces duration and volume of diarrhea in severe cases, based on susceptibility patterns reported by reference laboratories including the European Centre for Disease Prevention and Control. Electrolyte replacement, especially potassium, and monitoring for complications are standard in hospitals like Johns Hopkins Hospital and Mayo Clinic. Clinical management protocols have been promulgated in training curricula by organizations such as World Health Organization and The International Committee of the Red Cross for deployment in humanitarian crises.

Prevention and Public Health Measures

Prevention focuses on sustained improvements in water, sanitation, and hygiene (WASH) infrastructure exemplified by municipal projects in London and New York City; emergency measures include point‑of‑use chlorination, safe water trucking, and distribution of hygiene kits by agencies like UNICEF and Oxfam. Oral cholera vaccines (OCVs), including killed whole‑cell formulations prequalified by WHO, are used for reactive campaigns and preventive deployment coordinated by the Global Task Force on Cholera Control and partners such as Gavi, the Vaccine Alliance. Surveillance, case reporting, and multisectoral outbreak response engage public health institutions including Centers for Disease Control and Prevention, African Union, and national ministries, while long‑term control strategies align with the UN Sustainable Development Goals promoted by the United Nations. Lessons from historical interventions involving figures like John Snow and infrastructure reforms in cities such as Paris inform modern elimination initiatives.

Category:Infectious diseases